Epidemic risk projections powered by geo-intelligence
In 2020, we were joined by Dr. Jessie Abbate, a researcher in infectious disease ecology and epidemiology. We have since been working on a research and development project to design EpiWise, a platform for anticipating and communicating epidemiological threats influenced by fluctuating environmental factors, including animal and human behavior. This work provides access to geo-intelligence to produce risk indicators, early warnings and response services for governments and industry.
Anticipate to Mitigate
As our environment and behaviors continue to change, anticipating associated public health risks becomes more and more challenging.
Geospatial technologies can rapidly provide information about these crucial changes, a large volume of data that remains largely inaccessible for operational use for risk mitigation and response. This is where Geomatys comes in.
La solution EpiWise
The EpiWise project is based on Examind Datacube software, which features advanced mechanisms for on-the-fly data extraction and transformation while guaranteeing performance, enabling the processing of large quantities of geospatial data for use by epidemic risk models. Combining spatio-temporal analysis, AI/ML methods, simulation and classic epidemic modeling, EpiWise is capable of seamlessly integrating information from a variety of data sources to produce population risk classifications and support decision-making.est
Aspire with ESA
In 2022, Geomatys and the EpiWise project were named winners of the “Aspire With ESA” development grant, awarded to five innovative companies using geospatial data to help them bring their projects to fruition.
EpiWise and sustainable development
The EpiWise project responds directly to three of the UN's seventeen Sustainable Development Goals, namely SDG 3 (Good health and well-being), SDG 11 (Sustainable cities and communities), and SDG 13 (Combating climate change).
In the future...
With a demonstrator planned for 2024, EpiWise's development will initially focus on the epidemic risks posed by emerging infectious diseases, notably Ebola virus disease (EVD) and dengue fever. Stay informed by visiting our website at www.epiwise.com
